Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Content type

Project (6)
Result in Brief (6)
Report Summary (1)

Country

Algeria (1)
Argentina (1)
Belgium (5)
Canada (1)
China (1)
Croatia (1)
Czech Republic (3)
Denmark (4)
Estonia (1)
Finland (4)
France (7)
Germany (7)
Greece (2)
Hungary (1)
India (2)
Indonesia (1)
Italy (4)
Latvia (1)
Lithuania (1)
Mexico (1)
Morocco (1)
Netherlands (5)
Norway (4)
Philippines (1)
Poland (3)
Portugal (2)
Romania (2)
Russia (1)
Senegal (1)
Slovakia (3)
Slovenia (1)
South Africa (1)
Spain (2)
Sweden (3)
Switzerland (2)
Turkey (1)
United Kingdom (6)
United States (1)
Vietnam (1)

Advanced search

Search projects and results

Results 1 - 10 of 13
Results/page:
12 > 
Risk from pharmaceuticals in the environment
Concern over the presence of pharmaceuticals in the environment has resulted in greater research into the fate and effects of these bioactive substances. The EU-funded ‘Environmental risk assessment of pharmaceuticals’ (Erapharm) project investigated previously unstudied exposure routes involving terrestrial and aquatic environments.
Programme: FP6-SUSTDEV
Record Number: 89266
Last updated on: 2012-08-28
Available languages: DE, EN, ES, FR, IT, PL
L'impact des produits pharmaceutiques sur l'environnement
Les risques découlant de la présence de produits pharmaceutiques dans l'environnement ont conduit à davantage d'études sur le devenir et les effets de ces substances biologiquement actives. Le projet Erapharm («Environmental risk assessment of pharmaceuticals») financé par l'UE a étudié des voies d'exposition jusqu'ici négligées, et impliquant des environnements terrestres et aquatiques.
Programme: FP6-SUSTDEV
Record Number: 89266
Last updated on: 2012-08-28
Available languages: DE, EN, ES, FR, IT, PL
El riesgo de los productos farmacéuticos en el medio ambiente
La preocupación por la presencia de productos farmacéuticos en el medio ambiente ha desembocado en un mayor número de investigaciones relacionadas con el destino y los efectos de estas sustancias bioactivas. El proyecto Erapharm («Evaluación del riesgo medioambiental de los productos farmacéuticos»), financiado con fondos comunitarios, investigó vías de exposición relacionadas con los medios terrestres y acuáticos que no se habían estudiado hasta ahora.
Programme: FP6-SUSTDEV
Record Number: 89266
Last updated on: 2012-08-28
Available languages: DE, EN, ES, FR, IT, PL
I rischi ambientali provenienti dai prodotti farmaceutici
Le preoccupazioni relative alla presenza di prodotti farmaceutici nell'ambiente hanno condotto ad una più ampia ricerca sul destino e sugli effetti di queste sostanze bioattive. I fautori del progetto Erapharm ("Environmental risk assessment of pharmaceuticals"), finanziato dall'UE, hanno analizzato percorsi di esposizione finora sconosciuti che coinvolgono ambienti terrestri e acquatici.
Programme: FP6-SUSTDEV
Record Number: 89266
Last updated on: 2012-08-28
Available languages: DE, EN, ES, FR, IT, PL
Das Umweltrisiko von Arzneimitteln
Besorgnisse über Arzneimittel in der Umwelt haben zu einer verstärkten Forschung über das Schicksal und die Auswirkungen dieser bioaktiven Substanzen geführt. Das EU-geförderte Projekt ERAPharm ("Environmental risk assessment of pharmaceuticals") befasste sich mit bisher unerforschten Expositionswegen an Land und in Gewässern.
Programme: FP6-SUSTDEV
Record Number: 89266
Last updated on: 2012-08-28
Available languages: DE, EN, ES, FR, IT, PL
Negatywny wpływ farmaceutyków na środowisko
Niepokój związany z obecnością farmaceutyków w środowisku naturalnym spowodował, że podjęto szereg badań nad dalszymi losami i skutkami obecności tych bioaktywnych substancji w środowisku. W ramach finansowanego ze środków unijnych projektu "Farmaceutyki: ocena ryzyka środowiskowego" (Erapharm) przeanalizowano dotychczas niezbadane drogi narażenia, w tym środowisko wodne i lądowe.
Programme: FP6-SUSTDEV
Record Number: 89266
Last updated on: 2013-05-20
Available languages: DE, EN, ES, FR, IT, PL
Final Report Summary - ERAPHARM (Environmental risk assessment of pharmaceuticals)
The ultimate aim of the ERAPHARM project was to further advance the existing knowledge and procedures for the Environmental risk assessment (ERA) of human and veterinary pharmaceuticals. The specific objectives of the project were to: - investigate previously unexplored majo...
Programme: FP6-SUSTDEV
Record Number: 51872
Last updated on: 2011-04-14
Environmental risk assessment of pharmaceuticals
ID: 511135
Start date: 2004-10-01, End date: 2007-09-30
The overall objective of ERAPharm is to improve and complement existing knowledge and procedures for theenvironmental risk assessment (ERA) of human and veterinary pharmaceuticals. Based on EU regulatoryframeworks on the ERA of pharmaceuticals and on the outcome of previous pr...
Programme: FP6-SUSTDEV
Record Number: 74308
Last updated on: 2008-10-30
Integrated health, social and economic impacts of extreme events: Evidence, methods and tools
ID: 36877
Start date: 2007-02-01, End date: 2011-01-31
Recent events such as the Pakistan earthquake, Hurricane Katrina, the Indian Ocean tsunami and the European heat waves of 2003 reveal the vulnerability of societies to extreme events. The goal of this project is to strengthen prevention, mitigation and preparedness strategies ...
Programme: FP6-SUSTDEV
Record Number: 81278
Last updated on: 2011-03-01
Full-chain and Uncertainty approaches for assessing health risks in FUture eNvironmental scenarios
ID: 36976
Start date: 2007-02-01, End date: 2011-01-31
2-FUN aims to provide decision-makers with state of the art tools to analyse the current and future trends in environmental conditions and pressures that may lead to health problems. It will support the evaluation and ranking of management options through a range of functional...
Programme: FP6-SUSTDEV
Record Number: 81286
Last updated on: 2011-03-01
12 > 
List retrieved on: 2017-08-02
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top